Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 2009 March;75(3) > Minerva Anestesiologica 2009 March;75(3):135-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,623


eTOC

 

EXPERTS’ OPINION  FREEfree


Minerva Anestesiologica 2009 March;75(3):135-9

Copyright © 2009 EDIZIONI MINERVA MEDICA

language: English

Evidence-based renal replacement therapy for acute kidney injury

Zarbock A. 1, Singbartl K. 2, Kellum J. A. 2

1 Department of Anesthesiology and Intensive Care Medicine, University of Münster, Münster, Germany; 2 Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA


FULL TEXT  


Acute kidney injury (AKI) with the subsequent need for renal replacement therapy (RRT) represents a persistent challenge, arising in 4-5% in critically-ill patients, and remains associated with a high mortality (60%) and morbidity. As AKI is an independent risk factor for poor prognosis, appropriate management of patients with AKI becomes of utmost importance. Complications of AKI can be treated with different forms of RRT, such as continuous veno-venous hemofiltration or intermittent hemodialysis. However, the timing of the initiation, the modality, and the dose of RRT are still controversial and the subject of ongoing clinical trials. This review presents and discusses currently available data regarding the use of RRT in critically-ill patients with AKI.

top of page

Publication History

Cite this article as

Corresponding author e-mail